IMU in the Silicon Review, page-2

This is a good article indeed . Yes nothing new ....however it puts things into perspective .

As far as l know IMU are the main players globally in the B Cell space ...and at such an advanced stage .

I read articles etc about treatments etc which are all good .relating to imuno oncology ....but they are all about T cell treatments. Which rely on extremely expensive synthesized antibodies .

If the IMU B cell platform works to plan then it will eclipse those technologies .

Sorry to be preaching stuff most of us know ......but l genuinely think that the broader market just doesnt get this .

They just cant see it .....in their eyes IMU
is just another wanna be biotec in search of a cancer cure .

Really looking forward to 12 - 18 months time . If the IMU results are good ( clinical trials & observations of continued imune response from earlier trials ) Then the world will very much get it !!!

Will the stock price be 1.8 cents then ???

I doubt it !!!